Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
5(45%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_2
2
18%
Ph phase_3
2
18%
Ph not_applicable
3
27%
Ph phase_4
3
27%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
2(20.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
3(30.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

11

all time

Status Distribution
Active(7)
Completed(4)

Detailed Status

Completed4
Active, not recruiting3
Recruiting2
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (20.0%)
Phase 32 (20.0%)
Phase 43 (30.0%)
N/A3 (30.0%)

Trials by Status

not_yet_recruiting19%
recruiting218%
completed436%
active_not_recruiting327%
enrolling_by_invitation19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11